News

Gerresheimer Glass to close NJ pharmaceutical bottle plant this summer

Gerresheimer AG, the Germany-based drug packaging company, said it is laying off 140 workers and shuttering its Millville, NJ, glass operation this summer.

Symbiosis Pharmaceutical unveils new freeze-drying service for pharma industry

Symbiosis Pharmaceutical Services, a small CMO located in Scotland, said it is offering a new bulk lyophilisation (freeze-drying) service after getting new contract from the pharmaceutical industry.

Aurobindo Pharma submits abbreviated application to FDA for HIV drug production

India's Aurobindo Pharma has submitted an abbreviated new drug application (ANDA) to the FDA for the treatment of HIV as part of the country's pharmaceutical industry's efforts to ramp up production of drugs to treat HIV/AIDS.

Report: Claris Lifesciences injectables sale may hit roadblock by FDA Form 483

The Business Standard of India reports plans by Claris Lifesciences to sell its generic sterile injectables business may be thwarted by an adverse observation letter the company is reported to have gotten from the FDA.

Bayer set to spend $3.4M this year to expand its Indonesian operations

German pharmaceutical giant Bayer said it expects to spend $3.4 million to expand its Indonesian production capacity for effervescents this year.

Gilead Sciences plans $100M expansion of Edmonton plant

Gilead Sciences said it's investing an additional $100 million to expand its operations in Edmonton, Canada.

 

EU's medicines agency stands by recommendation to suspend drugs studied at GVK India facility

The European Medicines Agency is standing by its original recommendation made earlier this year to suspend a number of medicines that received European Union clearance based on clinical studies conducted by GVK Biosciences in India.

Report: Russia quickly becoming a major source of online fake pharma

A report by Deutsche Welle says roughly half of the prescription drugs sold online are fake, and Russia is quickly becoming a major source of bogus medications.

Strides Arcolab pays $287M for Aspen Pharmacare's Australian business

Strides Arcolab of India has agreed to buy Aspen Pharmacare's generic pharmaceutical business and related assets in Australia for $287 million.

Singapore moving to meet pharma manufacturing demand for high-quality water

Singapore, like other Asian countries looking to woo pharmaceutical manufacturers, is moving quickly to meet increasing demand for high-quality water required by strict regulations in the U.S. and European Union.

Law enforcement makes another illegal pharma supply chain bust; 2nd in U.S. in 8 days

For the second time in 8 days, law enforcement authorities have charged people with buying drugs illegally and reintroducing them into the legitimate supply chain.

Cipla pulls levalbuterol on FDA warning; Wockhardt removes other drugs on concerns

Cipla announced a drug recall of its asthma inhalant levalbuterol from the U.S. market following an FDA warning, and Wockhardt withdrew about a dozen drugs on manufacturing concerns at two of its plants in India.

Hospira recalls solution marked as heparin

Hospira is voluntarily recalling 181,704 bags of magnesium sulfate in 5% dextrose injections because labels on the immediate container may have barcodes indicating that it is instead the blood thinner heparin.

Zydus Cadila said to be buying Claris' sterile injectables biz as landscape morphs

Earlier this week, Endo said it would lay out $8 billion for Par Pharmaceuticals to get its hands on that company's sterile injectables biz. Now another deal is brewing in India forClaris Lifesciences operations in that part of the market.

Apotex recalling generic Zyprexa because the antipsychotic may be too weak

Canadian generics maker Apotex is recalling more than 35,000 bottles of generic Zyprexa, an antipsychotic, that were manufactured at a plant in Toronto that was recently nicked by the FDA for a number of issues.

Akorn antibiotic recall stems from its buyout of Hi-Tech

Illinois-based specialty generics maker Akorn is recalling more than 355,000 bottles of its generic of Bactrim made by one of its recent acquisitions, a company it blamed for some of its financial woes.

Fund grows to $200M for victims of meningitis outbreak tied to compounder

A fund for victims of a fungal meningitis outbreak that sprung from contaminated drugs sold by the now-defunct New England Compounding Center has reached $200 million, twice what was initially expected.

Medicago building $200M plant to manufacture vaccines from plants

Canada's Medicago, a biotech that is using plant technology to manufacture vaccines against Ebola and other viruses, will build a $200 million manufacturing facility in Quebec City. The company is getting substantial support from taxpayers but says when complete, it will more than double its workforce there.

Lannett adds Silarx's liquid manufacturing to its operations

Philadelphia-based generic maker Lannett says it has beefed up its manufacturing, and its generic portfolio, with the acquisition of Silarx for an undisclosed amount.

Pharmaniaga project in Saudi Arabia stalls but others move forward

A joint venture between Malaysia's Pharmaniaga and Saudi Arabia-based Modern Healthcare Solutions to build a pharma plant in Saudi Arabia appears unlikely to make it to the finish line.